Legal & General Group PLC Icad Inc Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$3.02 - $4.56 $6,849 - $10,342	-2,268 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$14.9 - $20.82 $2,786 - $3,893	187 Added 8.99%	2,268 $39,000
Q1 2021 May 17, 2021	SELL	$12.57 - $21.22 $135,278 - $228,369	-10,762 Reduced 83.8%	2,081 $44,000
Q3 2020 Nov 13, 2020	SELL	$8.56 - $11.6 $7,738 - $10,486	-904 Reduced 6.58%	12,843 $113,000
Q2 2020 Aug 14, 2020	BUY	$6.63 - $12.85 $91,142 - $176,648	13,747 New	13,747 $137,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $49.9M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.